ArticleScientific reports2026
Machine learning using PROFUND components for 30-day readmission prediction in multimorbid patients: a prospective multicentre study.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Early hospital readmission in multimorbid patients remains a major clinical challenge. Although risk stratification tools are widely used, predictive performance is often limited. The PROFUND index captures frailty, functional dependence, and social vulnerability, but its role in predicting 30-day readmission is unclear. In this prospective multicentre cohort study, multimorbid patients admitted to Internal Medicine and Geriatrics departments were followed after discharge. The primary outcome was unplanned 30-day readmission among patients surviving to 30 days. Models based on PROFUND components were developed using logistic regression and gradient boosting, including a calibrated ensemble model, and compared with LACE and HOSPITAL scores. Performance was assessed in an external validation cohort. Among 435 patients included in the readmission analysis, 14% were readmitted within 30 days. In external validation, discrimination remained modest (AUC 0.52-0.59). The ensemble XGBoost model achieved the highest AUC (0.59), followed by XGBoost (0.58), HOSPITAL (0.54), and LACE (0.52). Differences were incremental. SHAP analysis identified cognitive impairment, anaemia, advanced age, heart failure severity, functional dependence, and limited caregiver support as key contributors. Incorporating frailty, functional, and social vulnerability domains through PROFUND components resulted in only modest improvements in 30-day readmission prediction. Even with machine learning, discrimination remained limited. The observed performance likely reflects both the intrinsic complexity of short-term readmission and the constraints imposed by sample size and available predictors.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.